$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

$nhhs Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000150370719000012 Filed on May 10, 2019

Income Statement

Concept	2019 Q2	2019 Q1	2018 Q1
Revenue	$74.97M	$72.52M	$74.30M
YoY Change	3.02%	-2.4%	100.16%
Cost Of Revenue	$44.64M	$45.22M	$46.42M
YoY Change	-6.48%	-2.6%
Gross Profit	$30.34M	$27.30M	$27.88M
YoY Change	21.12%	-2.07%
Gross Profit Margin	40.46%	37.65%	37.52%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$15.96M	$22.40M	$28.82M
YoY Change	-41.94%	-22.28%	15.66%
% of Gross Profit	52.62%	82.04%	103.38%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$17.29M	$17.40M	$17.04M
YoY Change	-2.26%	2.1%	21.46%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$13.04M	-$18.44M	-$25.25M
YoY Change	-56.67%	-26.97%	18.01%
Income Tax	$15.00K	$6.000K	$15.00K
% Of Pretax Income
Net Earnings	-$17.15M	-$18.62M	-$33.67M
YoY Change	-49.71%	-44.7%	24.33%
Net Earnings / Revenue	-22.87%	-25.67%	-45.31%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	188.9M shares	189.1M shares	187.2M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$29.37M	$64.60M	$70.81M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$21.39M	$21.39M	$21.39M
YoY Change	0.0%	0.0%	-3.28%
Intangibles
YoY Change
Long-Term Investments	$288.9M	$260.3M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.186B	$2.230B	$2.433B
YoY Change	-8.18%	-8.34%	-18.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$1.479B	$1.503B	$1.531B
YoY Change	-3.23%	-1.82%	-16.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.000B	-$983.0M	-$793.3M
YoY Change	18.61%	23.9%	47.32%
Common Stock	$1.705B	$1.705B	$1.688B
YoY Change	0.83%	1.02%	0.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$701.4M	$720.3M	$895.2M
YoY Change
Total Liabilities & Shareholders Equity	$2.186B	$2.230B	$2.433B
YoY Change	-8.18%	-8.34%	-18.5%

Cashflow Statement

Concept	2019 Q2	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	-$17.15M	-$18.62M	-$33.67M
YoY Change	-49.71%	-44.7%	24.33%
Depreciation, Depletion And Amortization	$15.96M	$22.40M	$28.82M
YoY Change	-41.94%	-22.28%	15.66%
Cash From Operating Activities		-$2.019M	$7.269M
YoY Change		-127.78%	143.44%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$547.0K	$0.00
YoY Change			-100.0%
Cash From Investing Activities		$2.243M	$28.28M
YoY Change		-92.07%	-124.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.978M	$8.206M
YoY Change		-75.9%	-4.61%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-$13.71M	-$25.95M
YoY Change		-47.17%	-153.28%
NET CHANGE
Cash From Operating Activities		-$2.019M	$7.269M
Cash From Investing Activities		$2.243M	$28.28M
Cash From Financing Activities		-$13.71M	-$25.95M
Net Change In Cash		-$13.48M	$9.599M
YoY Change		-240.47%	-114.76%
FREE CASH FLOW
Cash From Operating Activities		-$2.019M	$7.269M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001503707
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	188921795	shares
CY2019Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	0	employee
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	NorthStar Healthcare Income, Inc.
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q1	nshi	Acquisition Feeand Expense Cap AcquisitionFeeandExpenseCap	0.06
	nshi	Common Stock Annualized Distribution CommonStockAnnualizedDistribution	0.675
CY2018	nshi	Common Stock Annualized Distribution CommonStockAnnualizedDistribution	0.3375
	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.00184932
CY2019Q1	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.000924658
CY2018	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.000924658
CY2018	nshi	Debt Instrument Numberof Instruments DebtInstrumentNumberofInstruments	1	Investment
CY2019Q1	nshi	Debt Instrument Numberof Instruments DebtInstrumentNumberofInstruments	1	Investment
CY2018Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	36996000	USD
CY2019Q1	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	30150000	USD
CY2019Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense After Year Five DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1917000	USD
CY2019Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense Remainderof Fiscal Year DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseRemainderofFiscalYear	1573000	USD
CY2019Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense Year Five DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseYearFive	337000	USD
CY2019Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense Year Four DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseYearFour	592000	USD
CY2019Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense Year Three DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1871000	USD
CY2019Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Amortization Expense Year Two DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2093000	USD
CY2019Q1	nshi	Deferred Costsand Finite Lived Intangible Assets Net DeferredCostsandFiniteLivedIntangibleAssetsNet	8383000	USD
CY2018Q1	nshi	Distributions Payable DistributionsPayable	5358000	USD
CY2019Q1	nshi	Distributions Payable DistributionsPayable	0	USD
CY2018Q1	nshi	Equity Method Investment Select Revenuesand Expenses Net EquityMethodInvestmentSelectRevenuesandExpensesNet	17785000	USD
CY2019Q1	nshi	Equity Method Investment Select Revenuesand Expenses Net EquityMethodInvestmentSelectRevenuesandExpensesNet	10084000	USD
CY2019Q1	nshi	Finance Lease Payments FinanceLeasePayments	200000	USD
CY2016Q1	nshi	Followon Public Offering FollowonPublicOffering	700000000	USD
CY2018Q4	nshi	Healthcare Facility Regulatory Reserve HealthcareFacilityRegulatoryReserve	6000000	USD
CY2019Q1	nshi	Healthcare Facility Regulatory Reserve HealthcareFacilityRegulatoryReserve	6000000	USD
CY2018Q1	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	978000	USD
CY2019Q1	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	-133000	USD
CY2019Q1	nshi	Investmentsinand Advanceto Affiliates Subsidiaries Associatesand Joint Ventures Numberof Facilities InvestmentsinandAdvancetoAffiliatesSubsidiariesAssociatesandJointVenturesNumberofFacilities	564	facility
CY2018Q1	nshi	Noncash Deconsolidation Variable Interest Entity NoncashDeconsolidationVariableInterestEntity	512772000	USD
CY2019Q1	nshi	Noncash Deconsolidation Variable Interest Entity NoncashDeconsolidationVariableInterestEntity	0	USD
CY2019Q1	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees	2500000	USD
CY2018Q1	nshi	Noncashor Part Noncash Transaction Acquisitionof Operating Real Estate Under Capital Lease Obligations NoncashorPartNoncashTransactionAcquisitionofOperatingRealEstateUnderCapitalLeaseObligations	1921000	USD
CY2019Q1	nshi	Noncashor Part Noncash Transaction Acquisitionof Operating Real Estate Under Capital Lease Obligations NoncashorPartNoncashTransactionAcquisitionofOperatingRealEstateUnderCapitalLeaseObligations	0	USD
CY2018Q1	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Financing Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsFinancingActivities	2885000	USD
CY2018Q1	nshi	Noncashor Part Noncash Transaction Issuanceof Common Stock Asset Management Fees NoncashorPartNoncashTransactionIssuanceofCommonStockAssetManagementFees	2500000	USD
CY2019Q1	nshi	Noncashor Part Noncash Transaction Issuanceof Common Stock Asset Management Fees NoncashorPartNoncashTransactionIssuanceofCommonStockAssetManagementFees	2500000	USD
CY2018Q1	nshi	Noncashor Part Noncash Transaction Reclassificationof Operating Real Estateto Assetsof Held For Sale NoncashorPartNoncashTransactionReclassificationofOperatingRealEstatetoAssetsofHeldForSale	14423000	USD
CY2019Q1	nshi	Noncashor Part Noncash Transaction Reclassificationof Operating Real Estateto Assetsof Held For Sale NoncashorPartNoncashTransactionReclassificationofOperatingRealEstatetoAssetsofHeldForSale	13513000	USD
CY2019Q1	nshi	Number Of Days Past Due For Suspension Of Income Recognition NumberOfDaysPastDueForSuspensionOfIncomeRecognition	P90D
CY2019Q1	nshi	Numberof Days Past Contractual Debt Service Payments Loan Categorizedasa Weaker Credit Quality Debt Investment NumberofDaysPastContractualDebtServicePaymentsLoanCategorizedasaWeakerCreditQualityDebtInvestment	P90D
CY2018	nshi	Numberof Properties Heldfor Sale NumberofPropertiesHeldforSale	1	property
CY2018Q1	nshi	Other Expense Securitization Trust OtherExpenseSecuritizationTrust	811000	USD
CY2019Q1	nshi	Other Expense Securitization Trust OtherExpenseSecuritizationTrust	0	USD
CY2018Q4	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	3025000	USD
CY2019Q1	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	2712000	USD
CY2018Q1	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	5910000	USD
CY2019Q1	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	2851000	USD
CY2019Q1	nshi	Percentof Interest Income Contributedby Investment PercentofInterestIncomeContributedbyInvestment	1
CY2019Q1	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Financing Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsFinancingActivities	6947000	USD
CY2019Q1	nshi	Related Party Transaction Dueto Related Parties Amount Incurred RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred	7925000	USD
CY2019Q1	nshi	Related Party Transaction Dueto Related Parties Amount Paid RelatedPartyTransactionDuetoRelatedPartiesAmountPaid	9004000	USD
CY2018Q1	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	73556000	USD
CY2017Q4	nshi	Shares Outstanding Weighted Average Numberof Shares Percentage SharesOutstandingWeightedAverageNumberofSharesPercentage	0.05
CY2017Q4	nshi	Stock Redeemed Or Called Price Paid Per Share StockRedeemedOrCalledPricePaidPerShare	8.50
CY2018Q1	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	2500000	USD
CY2019Q1	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	2500000	USD
CY2017Q4	nshi	Stock Redeemedor Called Price Paid Per Share Ninety Percentof Estimated Value StockRedeemedorCalledPricePaidPerShareNinetyPercentofEstimatedValue	7.65
CY2019Q1	nshi	Stock Repurchase Program Unfulfilled Requests StockRepurchaseProgramUnfulfilledRequests	85000000	USD
CY2019Q1	nshi	Stock Repurchase Program Unfulfilled Requests Shares StockRepurchaseProgramUnfulfilledRequestsShares	12000000	shares
CY2019Q1	nshi	Stock Repurchase Program Unfulfilled Requests Value Per Share StockRepurchaseProgramUnfulfilledRequestsValuePerShare	7.10
CY2018Q4	nshi	Utility Deposit Assets UtilityDepositAssets	325000	USD
CY2019Q1	nshi	Utility Deposit Assets UtilityDepositAssets	322000	USD
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	32405000	USD
CY2019Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	27545000	USD
CY2018Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	14436000	USD
CY2019Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	14736000	USD
CY2018Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	24000	USD
CY2019Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	26000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2284000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2084000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1697998000	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1703433000	USD
CY2018Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	4379000	USD
CY2019Q1	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	4246000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42188	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45000	USD
CY2018Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	722000	USD
CY2019Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	746000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	503000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	486000	USD
CY2018Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2783000	USD
CY2018Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2800000	USD
CY2019Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018Q4	us-gaap	Assets Assets	2264416000	USD
CY2019Q1	us-gaap	Assets Assets	2229610000	USD
CY2018Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	2183000	USD
CY2019Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	15696000	USD
CY2018Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	763000	USD
CY2019Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	38000	USD
CY2018Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2019Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1153000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	73811000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64600000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80488000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90087000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94508000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81024000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9599000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13484000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.08
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.03
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000.0	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	188495355	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	189255653	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	188495355	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	189255653	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1885000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	1893000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32925000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18417000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-33145000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-18469000	USD
CY2018Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	5605000	USD
CY2019Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	4799000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46424000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45218000	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	106269000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	93099000	USD
CY2018Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	5943000	USD
CY2019Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	4994000	USD
CY2018Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	670000	USD
CY2019Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	595000	USD
CY2019Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	11500000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28820000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22399000	USD
CY2018Q1	us-gaap	Dividends Common Stock DividendsCommonStock	15560000	USD
CY2019Q1	us-gaap	Dividends Common Stock DividendsCommonStock	5413000	USD
CY2018Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	5400000	USD
CY2019Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2018Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5675000	USD
CY2019Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	4596000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	176000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	131000	USD
CY2019Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	473723000	USD
CY2018Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2885000	USD
CY2019Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	6947000	USD
CY2019Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	6319162000	USD
CY2018Q4	us-gaap	Equity Method Investments EquityMethodInvestments	264319000	USD
CY2019Q1	us-gaap	Equity Method Investments EquityMethodInvestments	260345000	USD
CY2018Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	USD
CY2019Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2092000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2322000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	82000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	505000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	597000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	636000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	502000	USD
CY2019Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	230000	USD
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	142000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3200000	USD
CY2019Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.058
CY2019Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2018Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	14559000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	7788000	USD
CY2018Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	93371000	USD
CY2019Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	94202000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3687000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3054000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	21387000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	21387000	USD
CY2018	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	31000000	USD
CY2019Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	31000000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-25247000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18439000	USD
CY2018Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8626000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-224000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3417000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5820000	USD
CY2018Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	4654000	USD
CY2019Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	1421000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	996000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1688000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	189000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-465000	USD
CY2018Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-1764000	USD
CY2019Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	438000	USD
CY2018Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	36326000	USD
CY2019Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	29555000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	17038000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	17396000	USD
CY2018Q1	us-gaap	Interest Income Operating InterestIncomeOperating	3224000	USD
CY2018Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1580058000	USD
CY2019Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1568041000	USD
CY2018Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	3824000	USD
CY2019Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	0	USD
CY2018Q1	us-gaap	Investment Income Net InvestmentIncomeNet	3224000	USD
CY2019Q1	us-gaap	Investment Income Net InvestmentIncomeNet	1902000	USD
CY2018Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	264319000	USD
CY2019Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	260345000	USD
CY2018Q4	us-gaap	Land Land	236736000	USD
CY2019Q1	us-gaap	Land Land	236036000	USD
CY2018Q4	us-gaap	Land Improvements LandImprovements	22453000	USD
CY2019Q1	us-gaap	Land Improvements LandImprovements	22512000	USD
CY2018Q4	us-gaap	Lease Incentive Receivable LeaseIncentiveReceivable	1254000	USD
CY2019Q1	us-gaap	Lease Incentive Receivable LeaseIncentiveReceivable	1592000	USD
CY2019Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	188553000	USD
CY2019Q1	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	10919000	USD
CY2019Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	14907000	USD
CY2019Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	25072000	USD
CY2019Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	68268000	USD
CY2019Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	35122000	USD
CY2019Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	34265000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	1520042000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	1503491000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2264416000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2229610000	USD
CY2019Q1	us-gaap	Long Term Debt LongTermDebt	1488512000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	870060000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	18820000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	465140000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	64010000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	24296000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	46186000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	5699000	USD
CY2019Q1	us-gaap	Minority Interest MinorityInterest	5831000	USD
CY2018Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	150000	USD
CY2019Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	72000	USD
CY2018Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	58600000	USD
CY2019Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	58030000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25946000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13708000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	28276000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2243000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7269000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2019000	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-200000	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-220000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-52000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33668000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18617000	USD
CY2018Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	71000	USD
CY2019Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	256000	USD
CY2019Q1	us-gaap	Noninterest Income NoninterestIncome	72521000	USD
CY2018Q4	us-gaap	Notes Payable NotesPayable	1466349000	USD
CY2019Q1	us-gaap	Notes Payable NotesPayable	1461877000	USD
CY2019Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	segment
CY2019Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	75	property
CY2019Q1	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	10515	unit
CY2018Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	40749000	USD
CY2019Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	40286000	USD
CY2018Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	4300000	USD
CY2019Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	4000000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	196563000	USD
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	45700000	USD
CY2018Q4	us-gaap	Other Assets OtherAssets	14460000	USD
CY2019Q1	us-gaap	Other Assets OtherAssets	15836000	USD
CY2018Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	320000	USD
CY2019Q1	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	318000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	743000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	200000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	743000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	200000	USD
CY2018Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	380000	USD
CY2019Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	380000	USD
CY2018Q4	us-gaap	Other Liabilities OtherLiabilities	5834000	USD
CY2019Q1	us-gaap	Other Liabilities OtherLiabilities	5227000	USD
CY2018Q1	us-gaap	Other Operating Income OtherOperatingIncome	747000	USD
CY2019Q1	us-gaap	Other Operating Income OtherOperatingIncome	357000	USD
CY2018Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2019Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-547000	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8206000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1978000	USD
CY2018Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	20906000	USD
CY2019Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	10813000	USD
CY2018Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	106000	USD
CY2019Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2018Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	4470000	USD
CY2019Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	2400000	USD
CY2018Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	150000	USD
CY2019Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	72000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	3536000	USD
CY2019Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	4892000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1100000000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	10831000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	4876000	USD
CY2018Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	71000	USD
CY2019Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	256000	USD
CY2018Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	35771000	USD
CY2019Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-33888000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-18669000	USD
CY2018Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	367000	USD
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	325000	USD
CY2018Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	171083000	USD
CY2019Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	184594000	USD
CY2018Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1949997000	USD
CY2019Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1938387000	USD
CY2018Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1778914000	USD
CY2019Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1753793000	USD
CY2018Q4	us-gaap	Real Estate Investments RealEstateInvestments	1778914000	USD
CY2019Q1	us-gaap	Real Estate Investments RealEstateInvestments	1753793000	USD
CY2018Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	3495000	USD
CY2019Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	237000	USD
CY2018Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	181000	USD
CY2018Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	200000	USD
CY2018Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7299000	USD
CY2019Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5835000	USD
CY2018Q4	us-gaap	Restricted Cash RestrictedCash	20697000	USD
CY2019Q1	us-gaap	Restricted Cash RestrictedCash	16424000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-958924000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-982954000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	32807000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	31878000	USD
CY2018Q1	us-gaap	Revenues Revenues	74303000	USD
CY2019Q1	us-gaap	Revenues Revenues	72521000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	42000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	45000	USD
CY2015Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	108600000	shares
CY2018Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	10831000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	4876000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	42000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	45000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	738675000	USD
CY2018	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3300000	shares
CY2019Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	300000	shares
CY2017Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8000000	USD
CY2018	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	25900000	USD
CY2019Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2000000	USD
CY2018Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	8206000	USD
CY2019Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	1978000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	720288000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	944799000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	901182000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	744374000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	726119000	USD
CY2018Q1	us-gaap	Straight Line Rent StraightLineRent	359000	USD
CY2019Q1	us-gaap	Straight Line Rent StraightLineRent	189000	USD
CY2018Q4	us-gaap	Tenant Improvements TenantImprovements	11774000	USD
CY2019Q1	us-gaap	Tenant Improvements TenantImprovements	12797000	USD
CY2018	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	7.91
CY2019Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	7.10
CY2019Q1	us-gaap	Variable Interest Entity Nonconsolidated Carrying Amount Assets And Liabilities Net VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesNet	260300000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	187072856	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	189005931	shares
CY2019Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business and Organization</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), was formed to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, directly or through joint ventures, with a focus on the mid-acuity senior housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living (“ILF”) facilities and continuing care retirement communities (“CCRC”), which may have independent living, assisted living, skilled nursing and memory care available on one campus. The Company also invests in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but it also selectively makes international investments. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company conducts its operations so as to continue to qualify as a REIT for U.S. federal income tax purposes.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC (the “Prior Advisor”) and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), each an affiliate of the Company’s sponsor. The Prior Advisor invested </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> in the Operating Partnership in exchange for common units and the Special Unit Holder invested </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, the Company’s limited partnership interest in the Operating Partnership was </font><font style="font-family:inherit;font-size:10pt;">99.99%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s charter authorizes the issuance of up to </font><font style="font-family:inherit;font-size:10pt;">400.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock with a par value of </font><font style="font-family:inherit;font-size:10pt;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> per share and up to </font><font style="font-family:inherit;font-size:10pt;">50.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of preferred stock with a par value of </font><font style="font-family:inherit;font-size:10pt;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company completed its initial public offering (the “Initial Offering”) on February 2, 2015 by raising gross proceeds of </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;">, including </font><font style="font-family:inherit;font-size:10pt;">108.6 million</font><font style="font-family:inherit;font-size:10pt;"> shares issued in its initial primary offering (the “Initial Primary Offering”) and </font><font style="font-family:inherit;font-size:10pt;">2.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares issued pursuant to its distribution reinvestment plan (the “DRP”). In addition, the Company completed its follow-on offering (the “Follow-On Offering”) on January 19, 2016 by raising gross proceeds of </font><font style="font-family:inherit;font-size:10pt;">$700.0 million</font><font style="font-family:inherit;font-size:10pt;">, including </font><font style="font-family:inherit;font-size:10pt;">64.9 million</font><font style="font-family:inherit;font-size:10pt;"> shares issued in its follow-on primary offering (the “Follow-on Primary Offering”) and </font><font style="font-family:inherit;font-size:10pt;">4.2 million</font><font style="font-family:inherit;font-size:10pt;"> shares issued pursuant to the DRP. The Company refers to its Initial Primary Offering and its Follow-on Primary Offering collectively as the “Primary Offering” and its Initial Offering and Follow-On Offering collectively as the “Offering.” In December 2015, the Company registered an additional </font><font style="font-family:inherit;font-size:10pt;">30.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares to be offered pursuant to the DRP and continues to offer such shares, however, as of February 1, 2019, the Company suspended payment of monthly distributions to stockholders. From inception through </font><font style="font-family:inherit;font-size:10pt;">May 8, 2019</font><font style="font-family:inherit;font-size:10pt;">, the Company raised total gross proceeds of </font><font style="font-family:inherit;font-size:10pt;">$2.0 billion</font><font style="font-family:inherit;font-size:10pt;">, including </font><font style="font-family:inherit;font-size:10pt;">$232.6 million</font><font style="font-family:inherit;font-size:10pt;"> in DRP proceeds.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is externally managed and has </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> employees. The Company is sponsored by Colony Capital, Inc. (NYSE: CLNY) (“Colony Capital” or the “Sponsor”), which was formed as a result of the mergers of NorthStar Asset Management Group Inc.(“NSAM”), its prior sponsor, with Colony Capital, Inc. (“Colony”) and NorthStar Realty Finance Corp. (“NorthStar Realty”) in January 2017. Effective June 25, 2018, the Sponsor changed its name from Colony NorthStar, Inc. to Colony Capital, Inc. and its ticker symbol from “CLNS” to “CLNY.” Following the mergers, the Sponsor became an internally-managed equity REIT, with a diversified real estate and investment management platform. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Colony Capital manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded REITs and registered investment companies. The Company’s advisor, CNI NSHC Advisors, LLC (the “Advisor”), is a subsidiary of Colony Capital and manages its day-to-day operations pursuant to an advisory agreement.</font></div></div>
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions.</font></div></div>

Files In Submission

Name	View Source	Status
0001503707-19-000012-index-headers.html	Edgar Link	pending
0001503707-19-000012-index.html	Edgar Link	pending
0001503707-19-000012.txt	Edgar Link	pending
0001503707-19-000012-xbrl.zip	Edgar Link	pending
a33119piechartlocationv2.jpg	Edgar Link	pending
a33119piecharttype.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nshi-20190331.xml	Edgar Link	completed
nshi-20190331.xsd	Edgar Link	pending
nshi-20190331_cal.xml	Edgar Link	unprocessable
nshi-20190331_def.xml	Edgar Link	unprocessable
nshi-20190331_lab.xml	Edgar Link	unprocessable
nshi-20190331_pre.xml	Edgar Link	unprocessable
nshi0331201910-q.htm	Edgar Link	pending
nshi03312019exhibit311.htm	Edgar Link	pending
nshi03312019exhibit312.htm	Edgar Link	pending
nshi03312019exhibit321.htm	Edgar Link	pending
nshi03312019exhibit322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

2019 Q2 Form 10-Q Financial Statement

#000150370719000012 Filed on May 10, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS NorthStar Healthcare Income, Inc. Stock $nhhs

2019 Q2 Form 10-Q Financial Statement

#000150370719000012 Filed on May 10, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs